Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Laser Platform Contends with Acne Scarring

By HospiMedica International staff writers
Posted on 06 Aug 2014
An innovative picosecond (ps) laser with a disposable focused energy delivery system can be used for the treatment of acne scars.

The PicoSure ps aesthetic laser system delivers ultra-short 550 ps pulse bursts of energy to the skin, over 100 times shorter than nanosecond technology. More...
The ultra-short photomechanical burst magnifies pressure by 70%, enabling better scarring clearance, with fewer treatments and less fluence (energy delivered per unit area). For acne treatment, a closely packed array of diffractive lenses, called the Focus lens array, harnesses and redistribute each PicoSure pulse, thus exposing less than 10% of the skin to areas of high fluence.

Besides acne treatment, the PicoSure can be used for hair removal, treating vascular and benign pigmented lesions, remove multicolored tattoos, revitalizing the skin, liquefying and removing unwanted fat through laser lipolysis, reducing cellulite, clearing nails infected by toe fungus, and the ablation of sweat glands. The PicoSure picosecond aesthetic laser system is a product of Cynosure (Westford, MA, USA), and has been approved by the US Food and Drug Administration (FDA).

“Our Focus lens array microscopically concentrates laser energy on small treatment areas of tissue while stimulating collagen production and remodeling,” said Michael Davin, President and CEO of Cynosure. “With its unique pulse format, we believe Focus technology presents the opportunity for physicians to offer highly customizable treatments for their patients.”

Lasers with pulse widths in the picosecond regime can offer significant advantages over longer pulse lasers, with benefits that include virtually no heat affected zone and dramatically accelerated tattoo pigment fading. And the significantly lower energy fluences needed for the shorter pulse durations also reduces treatment pain.

Related Links:

Cynosure



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.